Our Science

At Eureka, our goal is to use our proprietary platforms to develop and commercialize novel therapies that realize the full potential of T-cell therapy in the treatment of cancer. We believe T-cell therapy represents a revolutionary step toward providing a potential cure for many forms of cancer, including cancers poorly addressed by current approaches.

We believe that together our ARTEMIS™ and E-ALPHA® platforms enable us to target a broader array of tumors in a wider therapeutic window with a potentially safer and more effective therapy than currently available options.

ARTEMIS™

Utilizing the natural biology of T-cells to fight cancer

learn more

E-Alpha®

Leveraging antibody discovery platform to develop highly specific antibodies

learn more